BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38414005)

  • 21. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
    Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
    BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.
    Bar EE; Lin A; Mahairaki V; Matsui W; Eberhart CG
    Am J Pathol; 2010 Sep; 177(3):1491-502. PubMed ID: 20671264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
    Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
    BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR/STAT3 under Hypoxic Conditions.
    Huang BR; Liu YS; Lai SW; Lin HJ; Shen CK; Yang LY; Lu DY
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel tumor-associated cell surface sialoglycoproteins in human glioblastoma tumors using quantitative proteomics.
    Autelitano F; Loyaux D; Roudières S; Déon C; Guette F; Fabre P; Ping Q; Wang S; Auvergne R; Badarinarayana V; Smith M; Guillemot JC; Goldman SA; Natesan S; Ferrara P; August P
    PLoS One; 2014; 9(10):e110316. PubMed ID: 25360666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.
    Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M
    Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.
    Seyfrid M; Maich WT; Shaikh VM; Tatari N; Upreti D; Piyasena D; Subapanditha M; Savage N; McKenna D; Mikolajewicz N; Han H; Chokshi C; Kuhlmann L; Khoo A; Salim SK; Archibong-Bassey B; Gwynne W; Brown K; Murtaza N; Bakhshinyan D; Vora P; Venugopal C; Moffat J; Kislinger T; Singh S
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35017149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glioblastoma Microenvironment and Invasiveness: New Insights and Therapeutic Targets.
    Erices JI; Bizama C; Niechi I; Uribe D; Rosales A; Fabres K; Navarro-Martínez G; Torres Á; San Martín R; Roa JC; Quezada-Monrás C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment.
    Xiao K; Tan J; Yuan J; Peng G; Long W; Su J; Xiao Y; Xiao Q; Wu C; Qin C; Hu L; Liu K; Liu S; Zhou H; Ning Y; Ding X; Liu Q
    J Cell Mol Med; 2020 Nov; 24(22):13235-13247. PubMed ID: 33009892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
    Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
    Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications.
    Yang L; Lin C; Wang L; Guo H; Wang X
    Exp Cell Res; 2012 Nov; 318(19):2417-26. PubMed ID: 22906859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glioblastoma spheroid growth and chemotherapeutic responses in single and dual-stiffness hydrogels.
    Bruns J; Egan T; Mercier P; Zustiak SP
    Acta Biomater; 2023 Jun; 163():400-414. PubMed ID: 35659918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
    Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
    Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics.
    Xing J; Cai H; Lin Z; Zhao L; Xu H; Song Y; Wang Z; Liu C; Hu G; Zheng J; Ren L; Wei Z
    Front Immunol; 2023; 14():1288137. PubMed ID: 38274828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration.
    Offer S; Menard JA; Pérez JE; de Oliveira KG; Indira Chandran V; Johansson MC; Bång-Rudenstam A; Siesjö P; Ebbesson A; Hedenfalk I; Sundgren PC; Darabi A; Belting M
    J Exp Clin Cancer Res; 2019 Jun; 38(1):241. PubMed ID: 31174567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FAT1 modulates EMT and stemness genes expression in hypoxic glioblastoma.
    Srivastava C; Irshad K; Dikshit B; Chattopadhyay P; Sarkar C; Gupta DK; Sinha S; Chosdol K
    Int J Cancer; 2018 Feb; 142(4):805-812. PubMed ID: 28994107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis identified core signal pathways and hypoxic characteristics of human glioblastoma.
    Gao Y; Zhang E; Liu B; Zhou K; He S; Feng L; Wu G; Cao M; Wu H; Cui Y; Zhang X; Liu X; Wang Y; Gao Y; Bian X
    J Cell Mol Med; 2019 Sep; 23(9):6228-6237. PubMed ID: 31282108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomics-based prognostic signature and nomogram construction of hypoxia microenvironment on deteriorating glioblastoma (GBM) pathogenesis.
    Wen YD; Zhu XS; Li DJ; Zhao Q; Cheng Q; Peng Y
    Sci Rep; 2021 Aug; 11(1):17170. PubMed ID: 34446747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Analysis of the Tumor Immune Microenvironment Landscape in Glioblastoma Reveals Tumor Heterogeneity and Implications for Prognosis and Immunotherapy.
    Zhao R; Pan Z; Li B; Zhao S; Zhang S; Qi Y; Qiu J; Gao Z; Fan Y; Guo Q; Qiu W; Wang S; Wang Q; Zhang P; Guo X; Deng L; Xue H; Li G
    Front Immunol; 2022; 13():820673. PubMed ID: 35309323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALKBH5 Facilitates Hypoxia-Induced Paraspeckle Assembly and IL8 Secretion to Generate an Immunosuppressive Tumor Microenvironment.
    Dong F; Qin X; Wang B; Li Q; Hu J; Cheng X; Guo D; Cheng F; Fang C; Tan Y; Yan H; He Y; Sun X; Yuan Y; Liu H; Li T; Zhao Y; Kang C; Wu X
    Cancer Res; 2021 Dec; 81(23):5876-5888. PubMed ID: 34670781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.